AutoAZTrader Posted - 2 days ago

$INDP New all-time low. Fucking great.

AutoAZTrader Posted - 2 days ago

$INDP Two cents away from all time low. What a fucking joke. Why is this still listed? Why was it ever listed?

jheerdink Posted - 2 days ago

$INDP Check out our new video featuring Chairman Dr. Roger Pomerantz, where he discusses his experience with #Keytruda while at Merck $Mrk and why Indaptus Therapeutics' broad immune-stimulating approach with Decoy20 could be the next leap forward in cancer treatment. https://youtu.be/TgF4HP6mtZo?si=qI-pfzN-YSLGPz8f

Biomechanika Posted - 4 days ago

$INDP Is there any milestone that could boost this?

RallyRaider Posted - 1 week ago

$INDP when multi dose

RallyRaider Posted - 1 week ago

$INDP pretty pincher down here

Biomechanika Posted - 1 week ago

$INDP Maxim Group PT is now $5. Great...

Biomechanika Posted - 1 week ago

$INDP Cash situation not looking good here. Wonder if they have a plan to secure the company's operation...

TwongStocks Posted - 2 weeks ago

$INDP SITC abstract is available here: https://jitc.bmj.com/content/12/Suppl_3/A1726

Biomechanika Posted - 2 weeks ago

$INDP They promised second cohort safety profile this year. Not much time left… Need some value here, no institutions interested yet. Cash is also running out.

RallyRaider Posted - 2 weeks ago

$INDP trying to bottom

jheerdink Posted - 2 weeks ago

$INDP Indaptus Therapeutics announces compelling safety, pharmacokinetics, and biomarker data on its lead compound, Decoy20, at the Society for Immunotherapy of Cancer (SITC) 2024 annual meeting. The data presented demonstrated that Decoy20 administered intravenously once weekly mainly showed side effects that were classified as mild or moderate and transient in duration. Further, pharmacokinetic analysis confirmed that Decoy20 quickly disappeared from the bloodstream after administration, supporting the Company’s “pulse” approach. One patient in the trial who has squamous cell carcinoma of the head and neck (SCCHN) with high levels of PD-L1, which is a protein that is associated with tumor response to certain immunotherapies, had “stable disease” — meaning the cancer had not progressed or worsened — at the time of their first imaging scan. https://finance.yahoo.com/news/indaptus-therapeutics-presents-encouraging-interim-130000687.html

aztecb Posted - 2 weeks ago

$INDP under one incoming ?

nostic Posted - 10/30/24

$RNAZ I bought into this knowing it could go to ZERO, so I risked what I could lose. To me it was a bet that could lose 100% or gain +500%, so I treated it like an option. People are obviously antsy about the delisting situation and shorts are probably in overdrive to keep the price down. But that doesn't matter all that much to me. I didn't buy this stock to make money on paper this quarter. In my opinion, there's a good chance this approach will work and eventually get FDA approval (or the company acquired before then). Perhaps the bigger threat I see is whether another company will develop a different type of treatment that's also highly effective ($GLUE or $INDP perhaps?). Maybe, but I think RNAZ will be marketable in the end. I'm confident $RNAZ will eventually raise funds to successfully complete the trials and POSSIBLY be worth $5-15B. Even if that means some dilution, it will still be a good investment, but of course I hope they can raise funds in other ways.

Stocks4thought Posted - 10/29/24

$INDP mECK FOLKERED- A SUPPLY AGREEMENT ISN'T A BIOTECH PARTNERSHIP= NO BIOBUCKS TRADED HANDS- NO FUNDING OF THE TRIAL- TO SPEAK............SAME OLD MECK.

hallmarktrader Posted - 10/28/24

$INDP I’m shocked by the pop. Thanks guys.

hallmarktrader Posted - 10/28/24

$INDP Short harder. Come on.

hallmarktrader Posted - 10/28/24

$INDP Guys, push it back down for me.

hallmarktrader Posted - 10/26/24

$INDP I’m going to try to get some of this under $1.20. We’ll see if it even drops that far. I can hope.

Stocks4thought Posted - 10/25/24

$INDP Meck power meal----------they thought they knew the story- misery loves company----------maybe one of the worst stocks- ever to own?

axelf0ley Posted - 10/25/24

$INDP Consider joining us! Misery loves company!

lemonyy Posted - 10/25/24

$INDP WTF

aztecb Posted - 10/25/24

$INDP welcome to INDP lots of you posted about it going up and here we are the same story as always 😂 rinse and repeat. Am I long on this ? Heck yes I’d say my holding for a private investor is considerably large in this company. I’m just realistic, this share is NOT for the feint hearted and a long therm investment.

GoGetIT0 Posted - 10/25/24

$INDP this company has no money.... No path forward here unfortunately. It's a shame that with the announcement earlier this week they didn't include a financial update of how they were expecting to proceed.

LewisDaKat Posted - 10/23/24

$INDP News out Indaptus Therapeutics to Present at Two Upcoming Investor Conferences https://marketwirenews.com/news-releases/indaptus-therapeutics-to-present-at-two-upcoming-inv-6340613860936310.html $INDP

jheerdink Posted - 10/23/24

$INDP https://www.investing.com/news/company-news/indaptus-therapeutics-partners-with-beigene-for-cancer-study-93CH-3675493

aztecb Posted - 10/23/24

$INDP don’t worry the drops not finished yet 😂

nostic Posted - 10/23/24

$INDP Excellent potential here and good looking chart. Check out their investor deck. Their therapy platform is called Decoy.

MA_007 Posted - 10/23/24

$INDP with the news we should be a lot higher, what is going on ?

Biomechanika Posted - 10/23/24

$INDP Phase 1 for eternity lol